L., Fanca-Berthon, P., & Williams, C
To make ends meet, some of Reshma Ramachandrans patients at a federally qualified health center in New Haven have turned to cash-pay, compounded versions of the drugs
(Tirzepatide is the active ingredient in Eli Lilly's obesity drug Zepbound.) She'd been taking the drugs already, from a local provider, and called them "life-changing," but made the switch to Zappy hoping to save money
So it will not cause any side effects in the stomach, intestines or thyroid
FDA has issued warnings about injectable glutathione after contamination events
CDC data confirms the urgency of accessible obesity care nationwide